Back to search

Carleton University

Examining the impact of poly- and perfluoroalkyl substances (PFAS) exposure on metabolic health

Abstract

dc:description.abstract

Poly- and perfluoroalkyl substances (PFAS) are a class of synthetic chemicals widely used in consumer and industrial products. PFAS are linked to numerous adverse health effects, including Type 2 diabetes (T2D). Epidemiological evidence suggests PFAS may impair metabolic adaptation during periods of increased physiological demand, such as pregnancy; however, few studies have investigated the effects of PFAS exposure on subclinical markers of metabolic health. In addition, while experimental evidence suggests that PFAS exposure may dysregulate insulin secretion in immortalized beta cell lines, no studies have investigated the effects on islet function in primary models. In this thesis, we used epidemiological and experimental approaches. Our epidemiological approach (Chapters 2-4) leveraged data from the Maternal-Infant Research on Environmental Chemicals (MIREC) study, a pan-Canadian longitudinal pregnancy study. We evaluated associations between prenatal legacy PFAS concentrations and markers of metabolic dysfunction measured during pregnancy and at 7-9 years follow-up. We also evaluated concurrently measured legacy and replacement PFAS and markers of beta cell function and glucose homeostasis at 7-9 years follow-up. We found prenatal PFAS concentrations were positively associated with inflammatory biomarkers, including a derived proinflammatory index measured during pregnancy, and markers of insulin resistance and beta cell dysfunction at 7-9 years follow-up. Our cross-sectional analysis showed that legacy PFAS were associated with beta cell dysfunction and decreased insulin resistance. Findings relevant to replacement PFAS and outcome measures were of smaller magnitude and less precise. In Chapter 5, we evaluated the biodistribution of legacy PFAS in mouse and human pancreas tissue and showed that PFOS more readily accumulates in pancreas than PFOA. We also show that acute and prolonged PFOS exposure suppresses insulin secretion in immortalized beta cells and had variable effects on insulin secretion in primary human donor islets. Perifusion analysis revealed that PFOS acutely amplified glucose-stimulated insulin secretion in male and female mouse islets. When PFOS was co-administered with a glucagon-like peptide (GLP)-1 antagonist, Exendin9-39, the acute insulin hypersecretion was partially suppressed. This thesis provides evidence that PFAS exposure may be linked to metabolic dysfunction, the impact of which may be particularly pronounced during pregnancy and/or post-partum.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy (Ph.D.)
Level thesis:degree_level
Doctoral
Discipline thesis:degree_discipline
Biology
Grantor dc:publisher
Carleton University
Year dc:date.issued
2025

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Palaniyandi, Jana

Subjects

dc:subject × 2

Rights

dc:rights
Statement dc:rights
  • Copyright © 2025 the author(s). Theses may be used for non-commercial research, educational, or related academic purposes only. Such uses include personal study, distribution to students, research and scholarship. Theses may only be shared by linking to the Carleton University Institutional Repository and no part may be copied without proper attribution to the author; no part may be used for commercial purposes directly or indirectly via a for-profit platform; no adaptation or derivative works are permitted without consent from the copyright owner.
Language dc:language.iso
en

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
Carleton University
Base URL
carleton.scholaris.ca/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Palaniyandi, Jana. Examining the impact of poly- and perfluoroalkyl substances (PFAS) exposure on metabolic health. Doctoral thesis, Carleton University, 2025. https://hdl.handle.net/20.500.14718/44729